Peptide Profiles — 2026-04-16
KPV (lysine-proline-valine) is a tripeptide derived from the C-terminal sequence of alpha-melanocyte-stimulating hormone (α-MSH). Despite its small size, KPV retains much of α-MSH's anti-inflammatory activity while lacking pigmentation effects — making it an interesting candidate for inflammation research.
KPV's anti-inflammatory effects appear mediated through multiple pathways: - NF-κB inhibition — Suppresses this master inflammatory signaling pathway - Cytokine modulation — Reduces TNF-α, IL-1β, IL-6, and other pro-inflammatory mediators - Melanocortin receptor independence — Unlike larger α-MSH fragments, KPV can act intracellularly - Neutrophil migration — Reduces immune cell infiltration to inflamed tissue - Nitric oxide modulation — Influences inducible NOS activity
KPV stands out among anti-inflammatory peptides for several reasons: 1. Size — Only three amino acids, offering stability and formulation flexibility 2. Specificity — Anti-inflammatory without pigmentation or appetite effects of full α-MSH 3. Multiple routes — Active via multiple administration routes in research 4. Intracellular action — Can act directly inside cells, not just at surface receptors
Disclaimer: All information presented in this article is for educational and informational purposes only. Platinum Biolabs does not promote or endorse the use of peptides for human consumption. All products sold by Platinum Biolabs are intended strictly for laboratory and research use only. Consult a qualified healthcare professional before making any health-related decisions.